InvestSMART

BlinkLab Limited (ASX: BB1) - Announcements

- Current share price for BB1 : $0.630

ASX company news and announcements for BlinkLab Limited (BB1) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All BlinkLab Limited (BB1) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than BlinkLab Limited (BB1), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for BlinkLab Limited (BB1)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$111 BB1 to Participate in Monash Uni Autism/ADHD MAGNET Project 13 Nov 2024 9:42AM $0.305 $0.630 risen by 106.56%
$111 Results of Annual General Meeting 8 Nov 2024 4:56PM $0.268 $0.630 risen by 135.51%
$111 Quarterly Activities/Appendix 4C Cash Flow Report 30 Oct 2024 9:46AM $0.260 $0.630 risen by 142.31%
$111 Amended AusBioInvest, JMM Lunch, BioFuture - Investor Presen 29 Oct 2024 11:45AM $0.265 $0.630 risen by 137.74%
$111 AusBioInvest, JMM Lunch, BioFuture - Investor Presentation 29 Oct 2024 9:09AM $0.260 $0.630 risen by 142.31%
$111 Letter to Shareholders and Proxy Form 4 Oct 2024 1:40PM $0.280 $0.630 risen by 125%
$111 Notice of Annual General Meeting & Proxy Form 4 Oct 2024 1:35PM $0.280 $0.630 risen by 125%
$111 Notification regarding unquoted securities - BB1 27 Sep 2024 6:23PM $0.220 $0.630 risen by 186.36%
$111 BB1 Signs Partnership for Clinical Trial with Euro INTER-PSY 12 Sep 2024 8:55AM $0.210 $0.630 risen by 200%
$111 Appendix 4G & Corporate Governance Statement 28 Aug 2024 4:44PM $0.218 $0.630 risen by 189.66%
$111 2024 Annual Report & Appendix 4E 28 Aug 2024 4:42PM $0.218 $0.630 risen by 189.66%
$111 Change of Director's Interest Notice 19 Aug 2024 9:17AM $0.240 $0.630 risen by 162.50%
$111 Change of Director's Interest Notice 15 Aug 2024 9:21AM $0.250 $0.630 risen by 152%
$111 The Pharmacology of Human Decision Making Study with Monash 6 Aug 2024 9:09AM $0.240 $0.630 risen by 162.50%
$111 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jul 2024 9:03AM $0.260 $0.630 risen by 142.31%
$111 BlinkLab Partners with Mental Care Group in Europe 30 Jul 2024 9:03AM $0.260 $0.630 risen by 142.31%
$111 BlinkLab to Present at TechKnow Invest 30 Jul 2024 8:22AM $0.260 $0.630 risen by 142.31%
$111 Study with Columbia University on Spinocerebellar Ataxias 24 Jul 2024 9:14AM $0.283 $0.630 risen by 123.01%
$111 BB1 Presentation - Bioshares Biotech Summit 12 Jul 2024 1:22PM $0.280 $0.630 risen by 125%
$111 Change of Director's Interest Notice 20 Jun 2024 9:32AM $0.250 $0.630 risen by 152%
$111 Change of Director's Interest Notice 18 Jun 2024 9:10AM $0.255 $0.630 risen by 147.06%
$111 Change of Director's Interest Notice 18 Jun 2024 9:03AM $0.255 $0.630 risen by 147.06%
$111 Change of Director's Interest Notice 17 Jun 2024 9:19AM $0.245 $0.630 risen by 157.14%
$111 Change of Director's Interest Notice 17 Jun 2024 9:17AM $0.245 $0.630 risen by 157.14%
$111 BlinkLab starts Clinical Study with Bates College 6 Jun 2024 9:01AM $0.310 $0.630 risen by 103.23%

151 - 175 of 198 results

Page 7 of 8

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.